Summary:
- The U.S. Food and Drug Administration (FDA) has granted full approval to Moderna's COVID-19 vaccine, known as Spikevax.
- This makes Moderna's vaccine the second COVID-19 vaccine to receive full approval from the FDA, after the Pfizer-BioNTech vaccine.
- The full approval of Moderna's vaccine is an important milestone, as it provides further confidence in the safety and effectiveness of the vaccine, which has been shown to be highly effective in preventing severe illness and hospitalization from COVID-19.